Can a new daily pill tame focal seizures?
NCT ID NCT06999902
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This trial is testing whether an experimental medication called PRAX-628 can reduce the frequency of focal seizures in adults with epilepsy who are already taking one to three other seizure medications. Participants will receive either PRAX-628 or a placebo for 12 weeks, with the dose increasing after the first 6 weeks. The main goal is to see if PRAX-628 leads to a greater reduction in monthly seizure frequency compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PRAX-628, an experimental oral medication taken once daily
- What this could lead to
- If successful, PRAX-628 could offer a new treatment option to help reduce focal seizures in adults with epilepsy who still have seizures despite taking other medications.
- What could go wrong
- This is an early-to-mid-stage trial, so the drug may not prove more effective than placebo. As with any new medication, there is also a risk of unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL SEIZURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Praxis Research Site
DeLand, Florida, 32720, United States
-
Praxis Research Site
Miami, Florida, 33133, United States
-
Praxis Research Site
Miami Lakes, Florida, 33016, United States
-
Praxis Research Site
Naples, Florida, 34116, United States
-
Praxis Research Site
Orlando, Florida, 32825, United States
-
Praxis Research Site
Chicago, Illinois, 60640, United States
-
Praxis Research Site
Lafayette, Louisiana, 70508, United States
-
Praxis Research Site
Bethesda, Maryland, 20817, United States
-
Praxis Research Site
Boston, Massachusetts, 02131, United States
-
Praxis Research Site
Plymouth, Michigan, 48170, United States
-
Praxis Research Site
Chesterfield, Missouri, 63005, United States
-
Praxis Research Site
Ozark, Missouri, 65721, United States
-
Praxis Research Site
Hackensack, New Jersey, 07601, United States
-
Praxis Research Site
Amherst, New York, 14226, United States
-
Praxis Research Site
Middletown, New York, 10940, United States
-
Praxis Research Site
New York, New York, 10016, United States
-
Praxis Research Site
Charlotte, North Carolina, 28211, United States
-
Praxis Research Site
Canton, Ohio, 44718, United States
-
Praxis Research Site
Oklahoma City, Oklahoma, 73112, United States
-
Praxis Research Site
Philadelphia, Pennsylvania, 19107, United States
-
Praxis Research Site
Sioux Falls, South Dakota, 57105, United States
-
Praxis Research Site
Memphis, Tennessee, 38104, United States
-
Praxis Research Site
Dallas, Texas, 75206, United States
-
Praxis Research Site
El Paso, Texas, 79912, United States
-
Praxis Research Site
Frisco, Texas, 75034, United States
-
Praxis Research Site
Round Rock, Texas, 78681, United States
-
Praxis Research Site
Seabrook, Texas, 77586, United States
-
Praxis Research Site
Waxahachie, Texas, 75165, United States
-
Praxis Research Site
Virginia Beach, Virginia, 23456, United States
-
Praxis Research Site
Campo Comprido, Curitiba PR, Brazil
-
Praxis Research Site
Belo Horizonte, Minas Gerais, Brazil
-
Praxis Research Site
Recife, Pernambuco, Brazil
-
Praxis Research Site
Rio de Janeiro, Rio de Janeiro, Brazil
-
Praxis Research Site
Porto Alegre, Rio Grande do Sul, Brazil
-
Praxis Research Site
Botucatu, São Paulo, Brazil
-
Praxis Research Site
Campinas, São Paulo, Brazil
-
Praxis Research Site
Ribeirão Preto, São Paulo, Brazil
-
Praxis Research Site
São José do Rio Preto, São Paulo, Brazil
-
Praxis Research Site
São Paulo, São Paulo, Brazil
-
Praxis Research Site
Surrey, British Columbia, Canada
-
Praxis Research Site
Toronto, Ontario, Canada
-
Praxis Research Site
Bologna, Italy
-
Praxis Research Site
Lecco, Italy
-
Praxis Research Site
Milan, Italy
-
Praxis Research Site
Monserrato, Italy
-
Praxis Research Site
Naples, Italy
-
Praxis Research Site
Pavia, Italy
-
Praxis Research Site
Pisa, Italy
-
Praxis Research Site
Ponderano, Italy
-
Praxis Research Site
Pozzilli, Italy
-
Praxis Research Site
Roma, Italy
-
Praxis Research Site
San Lucas Tepetlacalco, Mexico
-
Praxis Research Site
Bydgoszcz, Poland
-
Praxis Research Site
Katowice, Poland
-
Praxis Research Site
Lublin, Poland
-
Praxis Research Site
Warsaw, Poland
-
Praxis Research Site
Valladolid, Valladolid, Spain
-
Praxis Research Site
Barcelona, 08003, Spain
-
Praxis Research Site
Barcelona, 08035, Spain
-
Praxis Research Site
Barcelona, 08041, Spain
-
Praxis Research Site
Granda, 18012, Spain
-
Praxis Research Site
Madrid, 28006, Spain
-
Praxis Research Site
Madrid, 28010, Spain
-
Praxis Research Site
Madrid, 28040, Spain
-
Praxis Research Site
Málaga, 29010, Spain
-
Praxis Research Site
Terrassa, 08222, Spain
-
Praxis Research Site
Valencia, 46026, Spain
-
Praxis Research Site
Phoenix, Arizona, 85032, United States
-
Praxis Research Site
Loma Linda, California, 92345, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New seizure drug shows promise in large trial
- New pill aims to curb focal seizures in adults
- New epilepsy drug RAP-219 enters final testing phase
- Could ritalin sharpen your mind if you have epilepsy?
- Could a zapping headband tame tough seizures?
- New epilepsy drug vormatrigine tested for Long-Term safety in 700 adults